Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutrindo Ideais Research Center is a specialized clinical research facility based in Rio de Janeiro, Brazil, focusing on metabolic diseases, endocrinology, and sports medicine. The center operates as a high-performance site for Phase II, III, and IV clinical trials, partnering with global pharmaceutical companies to evaluate novel therapies for obesity, diabetes, and cardiovascular health. Led by Dr. Guilherme Renke, the institution integrates clinical practice with scientific rigor to advance evidence-based medicine in the fields of longevity and performance. It provides comprehensive infrastructure for patient recruitment, data management, and regulatory compliance within the Brazilian healthcare landscape. The center is recognized for its expertise in metabolic health and its ability to execute complex protocols for international sponsors. By bridging the gap between clinical care and pharmaceutical development, it plays a key role in the Latin American clinical research ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutrindo Ideais Research Center.